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Abstract 
Background: To evaluate the effectiveness of carotid 
artery  stenting in patients with carotid artery stenosis   
Methods: In this descriptive study rail roading 
technique was  used for carotid artery stenosis. An 8F 
multipurpose guide was mounted over a 5F JB3 diagnostic 
catheter. The whole assembly was passed over the guide 
wire and finally multipurpose guide was slided into  
internal carotid artery. The lesion was crossed with an 
appropriate size distal protection device which was then 
deployed in internal carotid artery, distal to the lesion. 
Predilatation was performed with a 2- to 3-mm coronary 
balloon. The self expanding tapering carotid stent was 
placed across the lesion and deployed. Post dilatation, if 
required, was done by ensuring that at least 15-20% 
residual stenosis was left behind.  
Results: In a total of 108 carotid artery stenting 
procedures, average age was 66.66 years. Majority (80.5%) 
were male. Embolic protection device was used in all. 
Majority (96.3%) achieved technical success  
Conclusion: Carotid Artery stenting is an  effective  
and safe treatment modality for internal carotid artery 
stenosis  
Key Words:Carotid Artery;Stenting;Embolic Protection 
Device 
 
Introduction 
      In Western countries, stroke is the third leading 
cause of death, after heart disease and cancer, and is 
the most common cause of permanent disability1.This 
neurological condition affects 0.2% of the population 
each year, and the incidence of stroke-related death is 
expected to double over the next 30 years. Stenosis of 
the internal carotid artery may be responsible for 10% 
to 20% of all strokes or transient ischemic attacks2. 
      Carotid endarterectomy (CEA) has been shown to 
reduce the incidence of stroke in patients with 
symptomatic and asymptomatic carotid stenosis. The 
American Heart Association guidelines support CEA 
for all symptomatic patients with ≥50% internal 
carotid artery stenosis and for asymptomatic patients 
with stenosis ≥60%, as long as the estimated 
perioperative death or stroke rate is <3% and life 
expectancy is ≥5 years. 3,4  
     With the recent advances in endovascular 
technology and with increasing experience of 
interventionists, carotid artery stenting (CAS) has 
challenged CEA as a treatment option for patients 
with carotid artery disease 
 
Patients and Methods 
    In this descriptive study patients undergoing 
carotid artery stenting over 6 years from Jan 2006 to 
July 2011, in Armed Forces Institute of Cardiology 
(AFIC), were studied.  5F venous sheath was passed 
into the femoral vein and a 5F TPM lead placed in the 
right ventricle for emergency pacing. 8F arterial sheath 
was passed in the femoral artery. A guide wire was 
advanced into the aorta under direct fluoroscopy. Rail 
roading technique was used and an 8F multipurpose 
guide was mounted over a 5F JB3 diagnostic catheter. 
This whole assembly was passed over the guide wire 
into the aortic arch. JB curve helped to engage the 
internal carotid artery (ICA) and guide wire was 
placed in the artery. Multipurpose guide was slided 
over this guide wire into the ICA and JB curve along 
with the guide wire was removed. A carotid 
arteriogram was obtained (in anteroposterior, lateral, 
and intracerebral views). The lesion was crossed with 
an appropriate size distal protection device which was 
then deployed in ICA distal to the lesion. Predilatation 
was performed with a 2- to 3-mm coronary balloon. 
The self expanding tapering carotid stent was placed 
across the lesion and deployed. Post dilatation, if 
required, was done but ensuring that at least 15-20% 
residual stenosis was left behind. A repeat carotid 
arteriogram along with cerebral views was done and 
wires and guide were removed. Pressure bandage was 
applied to the access site. Arterial and venous sheaths 
were removed 4 hours after the procedure. It was 
ensured that in the post procedure hospital stay blood 
pressure was kept under control and not allowed to 
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shoot to avoid hyperperfusion syndrome. Technical 
success was defined as the ability to access the carotid 
artery to successfully stent the lesion with 20 % or less 
residual stenosis.Study end points were defined as an 
occurrence within 30 days of minor stroke or major 
stroke or death. 
 
Results  
      The average age of the patients was 66.66 yrs (42yrs 
to 88yrs).There was male predominance(87.5%). In all 
the patients (n=108) embolic protection device was 
used. Out of 104 carotid stents deployed, 91.3% (n=95) 
were Acculink type (self expanding) stents and 8.7% 
(n=9) were others. Predilation was done in 37.1% 
(n=39) and in 62.9% (n=66) direct stenting was done.  
 
Table 1: Carotid Artery Stenting- Characteristics 
Characteristic No(%) 
Carotid Artery Involved 
Right ICA* 61(59.8%)  
Left ICA* 41(40.2) 
Embolic Protection Device 108(100) 
Accunet (Abbott Vascular) 95(91.3)  
Spide RX (Medtronic) 8(7.9) 
Total stents deployed= 104(96.3) 
Acculink stents 95(91.3) 
Others 9(8.7)  
Predilatation   39(37.1) 
Direct Stenting   66(62.9) 
Temporary Pacemaker 102(94.4) 
*ICA:Internal Carotid Artery  
 
     Temporary pacemaker(TPM) transvenous leads 
were used in 102/108 patients (94.4%)(Table 1). 
Accunet 6.5 was most commonly used (Table 2) . In 
4(3.7%) patients procedure was abandoned. Two  
(1.9%) patients suffered stroke during the procedure 
whereas 3 patients developed pericardial effusion due 
to TPM. 104 out of 108 (96.3%) cases achieved technical 
success (p= 0.003). Four (3.7%) procedures were 
abandoned  because of failure to engage the guide 
catheter in CCA(two patients) ,due to failure to cross a 
tortous vessel (one patient) and  due to  development 
of  bovine neck due to blood leakage (one patient).  
 
Discussion 
      Carotid artery stenting (CAS) increasingly emerges 
as an alternative to carotid endarterectomy (CEA) for 
the treatment of carotid stenoses 5,6,. Both CEA and 
CAS carry the burden of a small but clinically 
important rate of periprocedural complications—
mainly, cerebral ischemic events. In the Carotid and 
Vertebral Artery Transluminal Angioplasty Study 
(CAVATAS) there was no substantial difference in the 
rates of ipsilateral strokes between CEA and CAS over 
a 3 year follow up period.7 The Stenting and 
Angioplasty with Protection in Patients at High Risk 
for Endarterectomy (SAPPHIRE) trial CAS was found 
to be superior to CEA among high risk surgical 
patients.6 
 
Table 2: Size of Embolic Protection Device 
EPD Number (%) 
Accunet 4.0 1 (1) 
Accunet 4.5 7 (7.2) 
Accunet 5.5 13 (13.4) 
Accunet 6.5 43 (44.3) 
Accunet 7.5 18 (18.6) 
Spide RX 8 (82.0) 
EZ 7 (7.2) 
      In this descriptive analysis the high success rate 
can be ascribed primarily to  the use of EPD in all the 
patients. Embolic protection devices (EPDs) may lower 
the rate of ipsilateral ischemic events during CAS. This 
hypothesis is supported by data from registries , as 
well as an analysis from the Endarterectomy Versus 
Angioplasty in Patients With Symptomatic Severe 
Carotid Stenosis (EVA-3S) trial. 8,9  
           Direct stenting or predilation before stent 
deployment has always been a subject of debate in 
carotid artery stenting. In our study in 64.2% of cases 
direct stenting was done. In one study there was no 
statistically significant difference in outcome 
comparing direct stenting and predilation. 10  TPM was 
used in 92.9% (n=93) of the cases. Internationally 
TPMs are not recommended now,and use of 
intravenous atropine two minutes before balloon 
dilatation is considered sufficient.Probably there is 
also need to cut down use of TPMs to avoid risk of 
cardiac perforation. 11 
 
Conclusion 
The key to safe carotid stenting is avoiding high 
balloon pressures and repeated dilatations.    
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